Bristol-Myers Squibb Company
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| BMY | ABBV | BIIB | GILD | LLY | AMGN | |
|---|---|---|---|---|---|---|
| Market cap | 131.21B | 521.00B | 37.61B | 216.41B | 1.26T | 258.68B |
| P/E (TTM) | 14.2 | 50.7 | 110.2 | — | 46.0 | 27.7 |
| Forward P/E | 9.6 | 18.2 | 15.6 | 17.3 | 28.3 | 19.5 |
| Price/book | 5.6 | -113.7 | 2.0 | 16.6 | 31.4 | 18.0 |
| Dividend yield | 3.93% | 2.35% | — | 1.88% | 0.49% | 2.11% |
| 1-year change | +32.80% | +31.94% | +62.24% | +36.62% | +52.23% | +44.21% |
| Today | +4.02% | +3.09% | +2.22% | +4.19% | +0.61% | +3.73% |
The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 15 min.
Latest news
All BMY news ›BioNTech Q3: Bristol Myers Revenue Masks A Narrowing Oncology Bet (Rating Downgrade)
BioNTech earns a Hold rating as cash burn, pipeline narrowing, and two-asset concentration raise risk. Click here to read an analysis of BNTX stock now. - BioNTech is rated Hold due to a narrowing pipeline, negative cash flow, and reliance…
Gilead and Kite Advance Leadership With New Data Across Pipeline and Portfolio at ASH 2026
Nov 4, 2026 9:15am EST – iMMagine-1 Data Provide 18 Months Minimum Follow-Up on Anito-cel’s Durability and Safety in Relapsed or Refractory Multiple Myeloma – – Five-Year ZUMA-12 Follow-Up Data to Provide Long-Term Evidence for Yescarta®…
Harmony Biosciences Holdings, Inc. (HRMY) Q3 2026 Earnings Call Transcript
Harmony Biosciences Holdings, Inc. (HRMY) Q3 2026 Earnings Call November 4, 2026 8:30 AM EST Brennan Doyle - VP & Head of Investor RelationsJeffrey Dayno - President, CEO & DirectorPeter Anastasiou - Senior Executive VP & COOAdam Zaeske -…
Boehringer teams with Sino Biopharm on six early cancer programs under an agreement that could top $7 billion
Briefs Finance helps everyday people get better with money and invest with confidence, from getting out of debt all the way to investing like an expert. It starts with Market Briefs, a free five-minute daily newsletter, and grows into…
Biopharma likely to climb higher after ‘blue wave,’ analysts say
Historical data suggests the sector outperforms after midterm elections. And Democrats, newly in control of Congress, have “bigger fish to fry” than drug pricing, analysts said. The midterm elections have swung control of U.S. Congress…
Is Financing Sensitivity Weighing on Allergy Therapeutics (LSE:AGY)?
Is Home REIT (LSE:HOME) Rebuilding Value Through Its Restructuring? Is Vistry Group (LSE:VTY) Stabilising After a Turbulent Period? What Does Allergy Therapeutics Do? The company has a commercial base in Europe alongside a development…
Bright Minds Biosciences: Downgrade To 'Hold' On BMB-101 Setback DEE And Progression Into PWS
Bright Minds Biosciences is downgraded to "Hold" after the FDA placed a partial clinical hold on its BMB-101 IND for DEE. Click here to read more on DRUG. - Bright Minds Biosciences is downgraded from "Strong Buy" to "Hold" after the FDA…
Bristol Myers Squibb Company $BMY Stock Holdings Raised by Rakuten Investment Management Inc.
MarketBeat Bristol Myers Squibb Company $BMY Stock Holdings Raised by Rakuten Investment Management Inc. - Rakuten Investment Management increased its Bristol Myers Squibb stake by 9.6% in the third quarter
Gastric Cancer Market to Expand Rapidly by 2035 Amid Increasing Investments and Innovation | AstraZeneca, Daiichi Sankyo, Bristol-Myers Squibb, Amgen, Jazz Pharma, BeiGene, Zymeworks, ALX Oncology
Gastric Cancer Market to Expand Rapidly by 2035 Amid Increasing openPR.com Gastric Cancer Market to Expand Rapidly by 2035 Amid Increasing Investments and Innovation | AstraZeneca, Daiichi Sankyo, Bristol-Myers Squibb, Amgen, Jazz Pharma,…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketscreener.com41
- fool.com24
- seekingalpha.com23
- themarketsdaily.com22
- marketbeat.com21
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.